Join to access to all OVN content. Join for Free
The ART of Excellence... How to be a Rock Star MSL
medical affairs industry writing process adaptability resilience MSLs

The ART of Excellence... How to be a Rock Star MSL


Share This Article


Summary

In this episode, Cathy Andorfer joins Tom Caravela to discuss her new book and the journey of writing it. Cathy shares insights into her writing process, addressing challenges and the evolving landscape of the medical affairs industry. The conversation highlights the significance of adaptability and resilience for MSLs, along with maintaining a positive mindset amidst industry changes. Cathy reflects on the importance of these traits in her career and provides a glimpse into future industry trends. The episode wraps up with expressions of gratitude and a reminder about the upcoming Mass West event, followed by credits and sponsor information.

In this week’s episode, Cathy Andorfer, National MSL Director shares The ART of Excellence…How to become a Rock Star MSL

Click for Source
medical affairs industry, writing process, adaptability, resilience, MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Healthy on the Road-How to Avoid MSL Belly
Partner Avatar MSL Talk: Tom Caravela, Alex Palumbo

Healthy on the Road-How to Avoid MSL Belly

Podcast
The Strategic vs the Scientific MSL
Partner Avatar MSL Talk: Tom Caravela, Joy Morrell

The Strategic vs the Scientific MSL

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN